Live Breaking News & Updates on Nasdaq Krbp|Page 3
Stay updated with breaking news from Nasdaq krbp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kiromic BioPharma (NASDAQ:KRBP – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research report issued on Wednesday, Zacks.com reports. According to Zacks, “Kiromic BioPharma Inc. is a discovery and gene-editing company utilizing artificial intelligence and a proprietary neural network platform with a therapeutic focus on […] ....
Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Rating) – Equities researchers at Diamond Equity issued their Q1 2023 earnings per share (EPS) estimates for shares of Kiromic BioPharma in a research report issued to clients and investors on Thursday, May 19th. Diamond Equity analyst H. Diamond forecasts that the company will post earnings of ($0.43) per […] ....
Kiromic BioPharma, Inc. (NASDAQ:KRBP – Get Rating) was the recipient of a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 333,000 shares, a growth of 216.5% from the February 28th total of 105,200 shares. Based on an average daily trading volume, of 296,500 shares, […] ....